The Second International Anti-Cardiolipin Standardization Workshop/The Kingston Anti-Phospholipid Antibody Study (KAPS) Group
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Forty-three laboratories in 13 countries participated in a workshop to determine the degree of agreement between laboratories performing anticardiolipin tests. Each laboratory received freeze-dried aliquots of three samples labeled G1 (107 GPL units), G2 (20 GPL units), and G3 (6 GPL units) to be used as reference standards in the IgG assay, and three samples labeled M1 (106 MPL units), M2 (21 MPL units), and M3 (5 MPL units) as references for the IgM assay. Participating laboratories were divided into 8 groups and serum samples were exchanged between laboratories in each group. For IgG anticardiolipin, results were reported as: high, IgG positive for samples with optical absorbance readings exceeding G1; medium, IgG positive for samples with readings between G1 and G2; low, IgG positive between G2 and G3, and negative, if less than G3. In like manner, samples were defined as high-, medium-, or low-IgM positive, with reference to standards M1, M2, and M3. An index of agreement was computed to determine the degree of agreement between laboratories in each group. Interlaboratory agreement was excellent in each category assessed. For high positive and negative IgG and IgM results, the index of agreement exceeded 90%, and for medium and low positive results, agreement exceeded 75%. The overall index of agreement between laboratories exceeded 90%. The researchers conclude that the use of these six standards to obtain a semiquantitative measure of anticardiolipin positivity will enable good interlaboratory agreement in reporting anticardiolipin results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harris, E. N., Boey, M. L., Mackworth-Young, C. G., Gharavi, A. E., Patel, B. M., Loizou, S., & Hughes, G. R. V. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91267-9 · Cited by 1,383
Self-citationHarris, E. N., Gharavi, A. E., Patel, S., & Hughes, G. R. (1987) · PubMed · Cited by 723
Self-citationObstetric Complications Associated with the Lupus Anticoagulant
Branch, D. W., Scott, J. R., Kochenour, N. K., & Hershgold, E. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511213132104 · Cited by 560
Loizou, S., McCrea, J. D., Rudge, A. C., Reynolds, R., Boyle, C. C., & Harris, E. N. (1985) · PubMed Central · Cited by 549
Self-citationHarris, E. N. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.1986.00360230069012 · Cited by 543
Self-citation(1963) · PubMed · Cited by 512
Thrombosis in Patients with the Lupus Anticoagulant
MUEH, J. R., HERBST, K. D., & RAPAPORT, S. I. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-2-156 · Cited by 496
FETAL SURVIVAL AFTER PREDNISONE SUPPRESSION OF MATERNAL LUPUS-ANTICOAGULANT
Lubbe, W. F., Palmer, S. J., Butler, W. S., & Liggins, G. C. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92141-4 · Cited by 422
“Lupus” Anticoagulant and Thrombosis – Possible Role of Inhibition of Prostacyclin Formation
Carreras, L. O., & Vermylen, J. G. (1982) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657211 · Cited by 295
INTRAUTERINE DEATH AND CIRCULATING ANTICOAGULANT (“ANTITHROMBOPLASTIN”)
Nilsson, I. M., Åstedt, B., Hedner, U., & Berezin, D. (1975) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1975.tb04897.x · Cited by 293
Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody
Lockshin, M. D., Druzin, M. L., & Qamar, T. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90468-7 · Cited by 266
The Relationship Between Lupus Anticoagulants and Antibodies to Phospholipid
Triplett, D. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03720040042024 · Cited by 252
KALUNIAN, K. C., PETER, J., MIDDLEKAUFF, H., SAYRE, J., ANDO, D., MANGOTICH, M., & HAHN, B. (1988) · The American Journal of Medicine · doi:10.1016/s0002-9343(88)80229-8 · Cited by 148
Derksen, R. H. W. M., Hasselaar, P., Blokzijl, L., Gmelig-Meyling, F. H. J., & de Groot, P. G. (1988) · Annals of the Rheumatic Diseases · doi:10.1136/ard.47.5.364 · Cited by 139
Antibody to cardiolipin, lupus anticoagulant, and fetal death.
Lockshin, M. D., Qamar, T., Druzin, M. L., & Goei, S. L. (1987) · PubMed · Cited by 130
(1988) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068219 · Cited by 94
Cronin, M. E., Biswas, R. M., der Straeton, C. V., Fleisher, T., & Klippel, J. H. (1988) · PubMed · Cited by 82
Alving, B. M., Barr, C. F., & Tang, D. B. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90458-p · Cited by 48
Cited by
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203
Rai, R., Cohen, H., Dave, M., & Regan, L. (1997) · BMJ · doi:10.1136/bmj.314.7076.253 · Cited by 1,113
Underlying disorders associated with severe early-onset preeclampsia
Dekker, G. A., de Vries, J. I. P., Doelitzsch, P. M., Huijgens, P. C., von Blomberg, B. M. E., Jakobs, C., & van Geijn, H. P. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)91324-6 · Cited by 511
Oosting, J., Derksen, R., Bobbink, I., Hackeng, T., Bouma, B., & de Groot, P. (1993) · Blood · doi:10.1182/blood.v81.10.2618.2618 · Cited by 488
Metadata
- Authors
- Harris, E. N.
- Venue
- American Journal of Clinical Pathology
- Publisher
- Oxford University Press (OUP)
- Published
- 1990-10-01
- Volume
- 94
- Issue
- 4
- Pages
- 476-484
- ISSN
- 0002-9173 (ISSN-L)
- 1943-7722
- OpenAlex
- W2332313529
- Cited by
- 414
- References
- 18
- FWCI
- 18.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.